Baskent University Istanbul Hospital provides specialised Cystolitholapaxy with a focus on precise stone fragmentation, effective removal of bladder stone fragments, preservation of urinary tract structures, and individualized postoperative urological care. Established in 1993, the JCI, ISO accredited hospital is located in Istanbul, Turkey and operates 144 beds, with modern endourology, cystoscopy, laser technology, urinary imaging, and postoperative care infrastructure.

Cystolitholapaxy can provide an effective minimally invasive treatment option for appropriately selected patients with bladder stones. Treatment planning considers the number, size, and location of stones, urinary symptoms, bladder emptying function, recurrent infections, underlying causes of stone formation, and overall health. A detailed urological evaluation may also identify conditions such as bladder outlet obstruction or urinary retention that contributed to stone formation and may require additional management to reduce the risk of recurrence.